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Case report
An otherwise asymptomatic 55-year-old man with 
chronic hepatitis C, status postantiviral treatment with a 
normal alpha-fetoprotein (AFP), presented for routine fol-
lowup ultrasound (US) screening to exclude hepatocellular 
carcinoma (HCC). Previous screening US demonstrated a 
diffusely fatty liver but no focal liver lesions to suggest 
HCC. US tests performed at the time of  presentation 
showed multiple small round homogeneous hyperechoic 
liver masses in both lobes without associated mass effect or 
posterior acoustic enhancement (Fig. 1). No internal vascu-
larity appeared on Doppler evaluation. Subsequent mag-
netic resonance imaging (MRI) showed multiple small, ir-
regular areas of  signal loss on the opposed-phase compared 
to the in-phase sequence (Figs. 2A-D), consistent with mul-
tifocal areas of  focal fat deposition. A fat-suppressed T2-
weighted fast-spin-echo (FSE) image sequence showed ho-
mogeneous liver parenchyma without any focal lesions (Fig. 
2E). Contrast-enhanced axial 3-D fat-suppressed fast-
gradient-echo (GRE) images using gadobenate dimeglu-
mine (MultiHance, Bracco) did not show arterial phase 
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Hepatic steatosis is often seen in patients with hepatitis on screening ultrasound as generalized increased 
liver echogenecity. However, its nodular form can present as multiple echogenic masses, which can 
mimic hepatocellular carcinoma or metastasis by ultrasound and computed tomography. Small hepato-
cellular carcinomas are often hyperechoic and have a trend towards lower alpha-fetoprotein levels. Mag-
netic resonance imaging can accurately identify microscopic fat within the lesions and demonstrate lack 
of  associated enhancing soft tissue. If  this entity is not appropriately characterized using magnetic reso-
nance imaging, it can lead to additional imaging workup and unnecessary biopsy. 
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Figure 1. A 55-year-old man with chronic hepatitis C and 
multifocal nodular steatosis. US shows multiple focal hy-
perechoic hepatic masses.
enhancement or washout on the portal venous phase (Fig. 
2F, G) to suggest HCC. Since accurate characterization was 
done using MRI, a biopsy was not performed. The patient 
is currently being followed up using MRI and has not de-
veloped a HCC.
Discussion
Hepatic steatosis is a common finding with many differ-
ent imaging characteristics. It is usually diffuse or geo-
graphic but can be focal and, rarely, multifocal (1). When 
multifocal, it can mimic metastasis or HCC as seen on US 
and computed tomography (CT), which are used as screen-
ing tools for at-risk populations. If  hepatic steatosis is not 
recognized, unnecessary biopsy can result.  Accurate diag-
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Figure 2, A-D. A 55-year-old man with chronic hepatitis C and multifocal nodular steatosis. Axial MRI images at two levels 
show multiple small, irregular areas of signal loss on the opposed-phase compared to the in-phase sequence, consistent with 
multifocal areas of focal fat deposition
nosis depends on detection of  microscopic fat within the 
lesions, coupled with a lack of  associated enhancing soft 
tissue. 
Fat seen on US is mostly hyperechoic, although in some 
areas it may be hypoechoic. Hyperechoic lesions seen on 
US can be classified based on presence or absence of  a 
peripheral hypoechoic halo. Although some lesions have a 
variable appearance, the two most common lesions that are 
hyperechoic without a halo are focal fat and hemangioma 
(2-4).
Focal fatty infiltration often occurs in characteristic loca-
tions such as in the gall bladder fossa, adjacent to the falci-
form ligament, and anterior to the portal vein bifurcation in 
segment 4 (4, 5). Margins of  focal fat are geographic, and 
vessels are seen to course normally through the area of  
fatty infiltration without displacement or encasement. A 
typical cavernous hemangioma is uniformly echogenic with 
sharp margins, without a capsule, and with a hypoechoic 
halo. Posterior acoustic enhancement may be seen if  these 
are larger than 3 cm in size, but larger lesions can have 
atypical appearances on US (6). On Doppler imaging, there 
is absent to minimal flow within, but these lesions are never 
hypervascular. Such an appearance is diagnostic and is seen 
in approximately 80% of  hemangiomas. Both these lesions 
are benign, but when they are multifocal, further imaging is 
needed to exclude metastatic disease or multifocal HCC 
(especially if  there is underlying malignancy, hepatitis, cir-
rhosis, or chronic liver disease). A hypoechoic halo around 
a liver lesion is suspicious for malignancy and was not pre-
sent in our case (4).
Small HCCs have variable US echogenecity (4, 7, 8). 
These can be hypoechoic, hyperechoic, or isoechoic, or can 
have a nodule-in-nodule appearance, with the hypoechoic 
pattern being the most common. The hyperechoic pattern 
is more common in hepatitis C-related cirrhosis and in pa-
tients under 69 years, and it has a trend towards lower AFP 
levels (9) . 
On CT, fat is hypodense relative to the liver, with at-
tenuation values ranging from -10 to -100. A hypodense 
appearance on CT makes differentiation from focal liver 
tumor or metastatic disease difficult when the lesions are 
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Figure 2F, G. A 55-year-old man with chronic hepatitis C and multifocal nodular steatosis. Contrast-enhanced axial 3-D fat-
suppressed fast-gradient-echo images do not show areas of arterial enhancement or washout on the portal venous phase to 
suggest HCC.
Figure 2E. A 55-year-old man with chronic hepatitis C and 
multifocal nodular steatosis. Fat-suppressed T2-weighted 
fast-spin-echo (FSE) sequence shows a homogeneous liver 
parenchyma without any focal lesions.
multifocal. A central core of  normal-appearing hepatic 
tissue within focal areas of  fatty replacement (reversal of  
the typical tumor necrosis pattern) suggests hepatic steatosis 
(10). However, the most specific imaging technique to dem-
onstrate the presence of  fat is MRI.   
MRI using fat suppression and chemical shift imaging 
with opposed-phase sequences can detect even a small 
amount of  fat within lesions. During the in-phase, lipid and 
water signals are additive, but in the opposed-phase, the 
signal consists of  the water signal minus the lipid signal, 
allowing detection of  small amounts of  fat (11). 
The differential for liver lesions with only intracellular 
fat, without associated soft tissue, is small and consists of  
benign lesions such as focal steatosis, multifocal nodular 
steatosis, and some adenomas. Focal nodular hyperplasia 
(FNH) may have areas of  intracellular fat, but has associ-
ated soft tissue. Angiomyolipoma (AML) and adenoma can 
have both microscopic and macroscopic fat. HCCs have an 
associated soft-tissue component but can have both intra-
cellular and macroscopic fat. In general, hepatic metastases  
(with the exception of  liposarcomas) do not contain fat, 
though some cases have been reported. These are associ-
ated with a soft-tissue component (12).  
Fat is demonstrated in 10% of  hepatic adenomas on CT 
and in 36% to 77% on MRI (13-16). However, they can be 
heterogeneous from necrosis, old hemorrhage, or calcifica-
tion and can demonstrate early arterial enhancement with 
a centripetal pattern due to subcapsular feeding vessels. 
Enhancement does not persist because of  arteriovenous 
shunting. Lack of  uptake in the delayed phase using 
hepatocyte-specific contrast agents (gadolinium benzyloxy-
propionictetraacetate, Gd-BOPTA) distinguishes them from 
FNH (13). 
HCC is the most common malignant primary liver tu-
mor. Fatty change in HCCs is seen in up to 35% of  small 
HCCs (12, 17). Smaller HCCs usually have diffuse fatty 
change, while larger HCCs have patchy fatty change (5). 
Hyperintensity on T1-weighted images may relate to intra-
tumoral fat or hemorrhage, or to copper or zinc content of  
the surrounding liver parenchyma (18).
FNH is the second most common benign liver lesion after 
hemangioma; it is often incidental, and occurs in young 
asymptomatic women. On US, these are isoechoic and may 
show the characteristic "spoke-wheel" vascularity on color 
Doppler US (19). Fat within these lesions is rare, usually 
patchy, rarely peripheral, and may be associated with un-
derlying fatty liver (20). On CT and MRI, FNH demon-
strates intense homogeneous enhancement with rapid 
washout. A central scar bright on T2-weighted images with 
delayed enhancement is characteristic (12).
Hepatic involvement in Langerhans-cell histiocytosis is 
uncommon; it is seen in extensive disease and is associated 
with a high mortality rate. These lesions can look identical 
to multinodular hepatic steatosis but are characteristically 
located in the periportal regions with mass effect. This di-
agnosis should be considered if  there are stigmata of  the 
disease such as cutaneous, osseous, or pulmonary lesions 
with diabetes insipidus or pituitary insufficiency (12, 21).
Hepatic lipomas are rare, usually asymptomatic, with 
imaging characteristics typical of  lipomas. Fat is present in 
only 50% of  hepatic AMLs (22). Adrenal rest tumors are 
usually subcapsular, and they often contain macroscopic fat 
with briskly enhancing soft tissue. They can be difficult to 
distinguish from fat-containing HCCs (12).
In conclusion, we present the US and MRI findings for 
multifocal nodular steatosis and review the differential di-
agnosis of  liver lesions containing microscopic fat. In high-
risk patients, liver masses seen on screening raise the possi-
bility of  HCC. MRI has an advantage over other modali-
ties because of  its superior soft-tissue characterization. The 
use of  various MRI sequences allows for a confident diag-
nosis of  multifocal nodular steatosis. Awareness of  imaging 
findings of  this entity can avoid further workup and liver 
biopsy.
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